NEWYou can now listen to Fox News articles!
THE VILLAGES, Fla. – Some Americans questioned recent guidance the Biden administration issued stating that race or ethnicity could place patients at high risk of severe COVID-19 infection and more quickly qualify them for monoclonal antibodies and oral antiviral medications.
“We’re all in it, the virus is a virus, and you can get it no matter what you are,” Ben told Fox News.
President Biden in a recent photo. (AP Photo/Evan Vucci, File)
WATCH THE FULL STORY HERE:
“I don’t see why race is always mentioned nowadays,” Dave said. “You walk into a clinic, you should get taken care of. Whether you’re Black, White, Indian, Japanese, whatever your nationality is, it shouldn’t matter.”
The Food and Drug Administration approved emergency use authorizations of sotrovimab – a monoclonal antibody proven to be effective against the omicron variant – only to patients considered “high risk,” according to a fact sheet the agency released.
FDA sign at its headquarters in Washington.
The guidance, updated in December 2021, said “medical conditions or factors” such as